Is Baclofen a Controlled Substance?

Baclofen is not a controlled substance under United States federal law. The Drug Enforcement Administration (DEA) does not schedule it, which means it sits in a different regulatory category than drugs like benzodiazepines, opioids, or even gabapentin (which some states have scheduled). Baclofen is a prescription medication, so you still need a doctor’s order to obtain it legally, but pharmacies face none of the special tracking, storage, or reporting requirements that come with dispensing a controlled substance. That distinction matters practically, yet it also creates a gap between the drug’s legal status and its real-world risk profile, which is more complicated than its scheduling suggests.

What Baclofen Is and Why It Is Prescribed

Baclofen is a GABA-B receptor agonist, meaning it activates a specific type of receptor in the brain and spinal cord that dampens nerve signaling. It was originally developed as a more brain-penetrant version of GABA for epilepsy, but researchers discovered its strongest effect was relaxing skeletal muscles, and it was approved for treating spasticity instead.¹ It remains the only FDA-approved GABA-B agonist on the market. Doctors prescribe it primarily for spasticity caused by conditions like multiple sclerosis, spinal cord injuries, and cerebral palsy. It can be taken as an oral tablet or delivered directly into the spinal fluid through an implanted pump, known as intrathecal baclofen therapy.

Beyond spasticity, baclofen has attracted attention as a treatment for alcohol use disorder. A Cochrane systematic review covering 16 studies found that baclofen increases the percentage of days a person stays abstinent and likely reduces the risk of relapsing to any drinking.² France is the only country that has formally approved baclofen for this purpose.³ Elsewhere, prescribing it for alcohol problems is off-label, meaning it happens at the discretion of individual clinicians without regulatory endorsement for that use.

Prescription Drug Versus Controlled Substance

People often conflate “prescription” with “controlled,” but the categories are legally distinct. Thousands of prescription drugs, from blood pressure medications to antibiotics, require a doctor’s order without being scheduled under the Controlled Substances Act. Controlled substances carry extra layers of regulation: prescribers may need special licenses, pharmacies must keep detailed logs, refill limits are tighter, and law enforcement tracks distribution patterns. Baclofen has none of those requirements at the federal level. A doctor can call in a baclofen refill to your pharmacy just as easily as a refill for, say, a cholesterol medication.

A handful of U.S. states have considered or implemented additional monitoring for baclofen through their prescription drug monitoring programs, but these efforts are inconsistent and far less restrictive than formal scheduling. The practical upshot for most patients is that getting baclofen filled is straightforward: no special triplicate prescriptions, no limits on the number of refills a doctor can authorize at once, and no mandatory waiting periods between fills.

Why the Question Comes Up in the First Place

If baclofen were a completely unremarkable drug from an abuse standpoint, nobody would be searching this question. The reality is that baclofen does have properties that raise concern. It acts on the same broad inhibitory system in the brain that benzodiazepines and alcohol affect, though through a different receptor subtype. At higher doses, some people report euphoria, sedation, or a mood lift that can feel rewarding. Case reports have documented patients abusing baclofen specifically for its mood-elevating effects, particularly among people with co-occurring depression and alcohol dependence.⁴

A French case series examining non-medical use of baclofen found that the most common reason people misused the drug was to chase euphoria, and physical and psychological dependence developed in several of the individuals studied.⁵ These are not isolated anecdotes. U.S. poison center data from 2014 to 2017 showed that baclofen exposures rose by about 36%, and isolated abuse or misuse exposures specifically climbed by roughly 32% over that period. More than half of isolated baclofen exposures required admission to a healthcare facility, a rate considerably higher than for gabapentin exposures over the same period.⁶

The Withdrawal Problem

One of the most serious issues with baclofen, and a factor that distinguishes it from many unscheduled medications, is its withdrawal syndrome. Stopping baclofen abruptly after regular use can trigger a dangerous clinical picture that includes delirium, agitation, and instability in blood pressure, heart rate, and temperature. A review of published cases found that delirium was the hallmark psychiatric symptom of baclofen withdrawal, distinct from other psychiatric conditions, and that people receiving long-term therapy appeared more vulnerable.⁷ Unrecognized or undertreated baclofen withdrawal has been linked to serious harm and even death.

A 2025 systematic review confirmed this pattern, reporting that severe psychiatric disturbances appeared in up to about one in five withdrawal cases, typically emerging within one to four days after the drug was abruptly stopped. The most reliable treatment was simply restarting baclofen quickly.⁸ This withdrawal profile is clinically significant. Many drugs that are formally scheduled as controlled substances have milder discontinuation syndromes than baclofen does. The severity of baclofen withdrawal is one reason clinicians argue it deserves more regulatory attention than it currently receives.

Intrathecal Baclofen and Pump Failures

Patients who receive baclofen through an implanted pump face a unique version of the withdrawal risk. If the pump malfunctions or the catheter disconnects, the supply of baclofen to the spinal fluid stops suddenly, and the patient can deteriorate rapidly. One reported case involved a man with a spinal cord injury whose catheter disconnected, leading to severe spasticity, dangerously high body temperature, low blood pressure, muscle breakdown, and a life-threatening clotting disorder. High-dose benzodiazepines were not enough to control his symptoms; his condition only stabilized after the catheter was surgically repaired and intrathecal baclofen was resumed.⁹

For patients and caregivers managing an intrathecal baclofen pump, this means that pump alarms, missed refill appointments, or unexplained increases in spasticity should be treated as urgent. Emergency departments do not always recognize baclofen withdrawal from a pump failure immediately, especially if the patient cannot communicate. It is one of the more dangerous non-controlled-substance withdrawal scenarios in medicine.

Kidney Disease and Baclofen Toxicity

Baclofen is cleared primarily by the kidneys, so people with reduced kidney function are at heightened risk of the drug accumulating to toxic levels, even at standard doses. A large study found that the risk of encephalopathy, a serious brain dysfunction, increased progressively as kidney function declined. In people with severely reduced kidney filtration, the added risk was nearly 3%.¹⁰ That may not sound dramatic in percentage terms, but encephalopathy from baclofen can mimic stroke, seizures, or sepsis, leading to misdiagnosis and delayed treatment. For anyone with chronic kidney disease, the margin of safety with baclofen is thinner, and the fact that the drug is unscheduled can create a false sense that it is low risk.

Toxicology experts have noted that potential interactions with other central nervous system depressants, including alcohol, benzodiazepines, and opioids, should be carefully considered when prescribing baclofen, since combining these substances compounds the sedation and respiratory depression risk.¹¹ This is particularly relevant when baclofen is used off-label for alcohol problems, because the patient population often has coexisting liver or kidney damage and may be using other substances.

Rising Poisoning Cases

The gap between baclofen’s unscheduled status and its clinical risk is reflected in poisoning trends. In France, where baclofen prescribing for alcohol use disorder expanded rapidly during the 2010s, poisoning cases reported to a major poison control center rose from 8 in 2008 to 91 in 2015, driven largely by patients who had been prescribed the drug for alcohol problems.¹² The U.S. has seen a parallel trend: intentional baclofen exposures reported to poison centers, including suspected suicide attempts, increased by about 43% between 2014 and 2017.¹³

From a forensic standpoint, baclofen deaths remain poorly characterized. A review of the forensic literature found that very few published reports present complete autopsy findings in baclofen fatalities, and no studies have addressed how the drug redistributes in the body after death, which makes it harder to determine whether baclofen caused or contributed to a death after the fact.¹⁴ The scarcity of forensic data means baclofen’s contribution to overdose deaths may be undercounted.

Online Availability and the Unregulated Market

Because baclofen is not a controlled substance, it occupies a gray zone in online pharmaceutical commerce. A study examining baclofen availability on the internet found it for sale through 38 online pharmacies, of which only one complied with UK regulations.¹⁵ The ease of acquiring baclofen online, often without a legitimate prescription, creates a supply channel that would not exist for a scheduled drug. Controlled substances are subject to tighter international shipping restrictions and more aggressive enforcement against rogue online pharmacies. An unscheduled prescription drug like baclofen slips through those nets more easily.

This matters in particular for people who use baclofen recreationally or to self-treat alcohol dependence without medical supervision. Without the safeguards that come with controlled-substance dispensing, such as pharmacist verification, prescription monitoring, and quantity limits, people can stockpile the drug or obtain it from multiple sources simultaneously. The combination of easy access and a genuine withdrawal syndrome is a setup for harm.

How Baclofen Compares to Gabapentin’s Regulatory Trajectory

Gabapentin offers a useful comparison. For years, gabapentin was an unscheduled prescription drug, much like baclofen is today. As evidence of misuse, diversion, and withdrawal accumulated, several U.S. states began scheduling gabapentin as a controlled substance (Kentucky was among the first, in 2017), and it has since been added to prescription monitoring programs in many states. Gabapentin’s path from unscheduled to partially regulated was driven by the same kinds of signals now appearing in the baclofen literature: rising poison center reports, documented cases of abuse and dependence, and a withdrawal syndrome with genuine medical consequences.

Whether baclofen follows a similar trajectory is uncertain. The drug’s overall prescribing volume is smaller than gabapentin’s, which may keep it below the regulatory radar for longer. But the trend lines, particularly the climbing rates of misuse, poisoning, and emergency department visits, echo what preceded gabapentin’s reclassification in some jurisdictions. If you are a patient taking baclofen, the practical point is to treat the drug with the same respect you would give a controlled substance, even if the law does not require it.

What This Means If You Take Baclofen

The fact that baclofen is not a controlled substance simplifies your experience at the pharmacy but should not change how carefully you handle the medication. A few things worth knowing:

Never stop abruptly: Tapering under medical guidance is essential, especially if you have been taking baclofen for weeks or longer. Withdrawal can be dangerous and comes on within days of stopping.
Kidney function matters: If you have any degree of kidney disease, your doctor should be adjusting the dose accordingly and monitoring you more closely. Routine doses can become toxic when the kidneys cannot clear the drug efficiently.
Watch for interactions: Combining baclofen with alcohol, benzodiazepines, opioids, or sleep medications amplifies sedation and respiratory depression. This is especially relevant for people prescribed baclofen off-label for alcohol problems, where the temptation to drink while on the medication is part of the clinical picture.
Pump patients need vigilance: If you have an intrathecal baclofen pump, any sudden increase in spasticity, fever, or change in mental status could signal a pump malfunction. This is a medical emergency.

The Alcohol Use Disorder Prescribing Landscape

The off-label use of baclofen for alcohol dependence adds a layer of complexity to the scheduling question. When baclofen is prescribed for spasticity, doses typically stay in the range of 30 to 80 milligrams per day. For alcohol use disorder, however, some clinicians titrate much higher, sometimes beyond 300 milligrams per day, because some patients only respond at elevated doses.¹⁶ No optimal fixed dose has been established for this indication, and the existing evidence on how well it works is inconsistent. The Cochrane review found benefits in terms of abstinent days and reduced relapse risk, but also noted that baclofen increases side effects like fatigue, dizziness, sedation, and dry mouth.¹⁷

High-dose prescribing for alcohol problems, in a patient population that often has psychiatric comorbidities and access to other substances, raises the stakes. France’s experience is instructive: as baclofen use for alcohol disorder expanded, poisoning cases surged.¹⁸ France ultimately imposed dose caps and tighter prescribing guidelines through successive regulatory measures. These steps functioned as a form of heightened control without formally scheduling the drug, an approach that reflects the tension between baclofen’s therapeutic promise and its real risks. Patients considering baclofen for alcohol problems should know that this remains an area where the evidence is evolving and medical monitoring is not optional; it is the minimum standard of safe use.